Literature DB >> 26221374

Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma.

Weifeng Tang1, Yu Chen2, Shuchen Chen1, Bin Sun3, Haiyong Gu3, Mingqiang Kang1.   

Abstract

Polymorphisms in gene encoding programmed death-1 (PD-1) were suggested to be associated with the risk of multiple cancers. To the best of our knowledge, no investigation has been carried out for gastric cardia adenocarcinoma (GCA) and PD-1 polymorphisms. Thus, we studied PD-1 rs10204525 A>G, rs7421861 T>C and rs2227982 C>T single nucleotide polymorphisms (SNPs) in 330 GCA cases and 608 cancer-free controls. Genotypes of PD-1 SNPs were determined by ligation detection reaction (LDR) assays. The distributions of the allele and genotype were not statistically significant in two groups for the three PD-1 SNPs. However, in stratified analyses by various characteristics (eg., age, sex, smoking condition and alcohol consumption status), we found a significantly increased risk of GCA associated with the PD-1 rs2227982 C>T polymorphism was evident among ever drinking cases (TT vs. CC: adjusted OR = 2.53, 95% CI = 1.11-5.79, P = 0.028; TT+CT vs. CC: adjusted OR = 2.04, 95% CI = 1.01-4.13, P = 0.047). For the other SNPs, in stratified analyses, no correlation between the SNPs and susceptibility of GCA was observed. In conclusion, our results highlight that rs2227982 C>T polymorphism in PD-1 gene may contribute to the risk of GCA.

Entities:  

Keywords:  Polymorphism; gastric cardia adenocarcinoma; immunoglobulin superfamily; programmed death-1; susceptibility

Year:  2015        PMID: 26221374      PMCID: PMC4509319     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  34 in total

1.  Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer.

Authors:  Emma L Ivansson; Ivana Juko-Pecirep; Ulf B Gyllensten
Journal:  Gynecol Oncol       Date:  2009-12-02       Impact factor: 5.482

Review 2.  Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.

Authors:  Manuel Vial; Luis Grande; Manuel Pera
Journal:  Recent Results Cancer Res       Date:  2010

3.  Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study.

Authors:  Süleyman Bayram; Hikmet Akkız; Yakup Ülger; Aynur Bekar; Ersin Akgöllü; Selçuk Yıldırım
Journal:  Gene       Date:  2012-10-04       Impact factor: 3.688

4.  Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.

Authors:  Zhu Li; Na Li; Qianqian Zhu; Guoyu Zhang; Qunying Han; Pingping Zhang; Meng Xun; Yawen Wang; Xiaoyan Zeng; Cuiling Yang; Zhengwen Liu
Journal:  Infect Genet Evol       Date:  2013-01-02       Impact factor: 3.342

Review 5.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

6.  The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

Authors:  Hazem Ghebeh; Shamayel Mohammed; Abeer Al-Omair; Amal Qattan; Cynthia Lehe; Ghofran Al-Qudaihi; Naser Elkum; Mohamed Alshabanah; Suad Bin Amer; Asma Tulbah; Dahish Ajarim; Taher Al-Tweigeri; Said Dermime
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

7.  New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer.

Authors:  Valeska B Guzman; Anatoly Yambartsev; Amador Goncalves-Primo; Ismael D C G Silva; Carmen R N Carvalho; Julisa C L Ribalta; Luiz Ricardo Goulart; Natalia Shulzhenko; Maria Gerbase-Delima; Andrey Morgun
Journal:  Hum Mol Genet       Date:  2008-03-12       Impact factor: 6.150

8.  PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.

Authors:  Wenshi Wang; Roy Lau; Daohai Yu; Weiwei Zhu; Alan Korman; Jeffrey Weber
Journal:  Int Immunol       Date:  2009-08-03       Impact factor: 4.823

9.  Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer.

Authors:  Tong Sun; Yifeng Zhou; Ming Yang; Zhibin Hu; Wen Tan; Xiaohong Han; Yuankai Shi; Jiarui Yao; Yongli Guo; Dianke Yu; Tian Tian; Xiaoyi Zhou; Hongbing Shen; Dongxin Lin
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

10.  Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with gastric cancer.

Authors:  Sanaz Savabkar; Pedram Azimzadeh; Vahid Chaleshi; Ehsan Nazemalhosseini Mojarad; Hamid Asadzadeh Aghdaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more
  18 in total

Review 1.  Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Sabina Sandigursky; Adam Mor
Journal:  Curr Rheumatol Rep       Date:  2018-09-06       Impact factor: 4.592

2.  The prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonography.

Authors:  Lin-Ang Wang; Xi Wei; Qing Li; Lin Chen
Journal:  Tumour Biol       Date:  2015-12-15

Review 3.  PD-1 and cancer: molecular mechanisms and polymorphisms.

Authors:  Arash Salmaninejad; Vahid Khoramshahi; Alireza Azani; Ehsan Soltaninejad; Saeed Aslani; Mohammad Reza Zamani; Masoud Zal; Abolfazl Nesaei; Sayed Mostafa Hosseini
Journal:  Immunogenetics       Date:  2017-06-22       Impact factor: 3.330

Review 4.  Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies.

Authors:  Wenjing Dong; Mancheng Gong; Zhirong Shi; Jianjun Xiao; Junkai Zhang; Jiewen Peng
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

Review 5.  The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis.

Authors:  Jie Zhang; Taiqiang Zhao; Chengjie Xu; Jiang Huang; Hua Yu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the Chinese Han population: A case-control study involving 2,740 subjects.

Authors:  Weifeng Tang; Shuchen Chen; Yu Chen; Jihong Lin; Jiangbo Lin; Yafeng Wang; Chao Liu; Mingqiang Kang
Journal:  Oncotarget       Date:  2017-06-13

Review 7.  Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.

Authors:  Mohamed Abozeid; Antonio Rosato; Roberta Sommaggio
Journal:  Biomed Res Int       Date:  2017-07-11       Impact factor: 3.411

8.  Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population.

Authors:  Sheng Zhang; Jiakai Jiang; Zhan Chen; Yafeng Wang; Weifeng Tang; Yu Chen; Longgen Liu
Journal:  Onco Targets Ther       Date:  2018-08-08       Impact factor: 4.147

9.  PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women: A Hospital-Based Observational Study.

Authors:  Hong-Tao Ren; Yi-Ming Li; Xi-Jing Wang; Hua-Feng Kang; Tian-Bo Jin; Xiao-Bin Ma; Xing-Han Liu; Meng Wang; Kang Liu; Peng Xu; Qing-Ling Yao; Zhi-Jun Dai
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

10.  Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case-control study in Eastern Chinese Han population.

Authors:  Sheng Zhang; Jiakai Jiang; Zhan Chen; Yafeng Wang; Weifeng Tang; Chao Liu; Longgen Liu; Yu Chen
Journal:  Onco Targets Ther       Date:  2018-04-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.